BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9393954)

  • 1. Metyrapone is a competitive inhibitor of 11beta-hydroxysteroid dehydrogenase type 1 reductase.
    Sampath-Kumar R; Yu M; Khalil MW; Yang K
    J Steroid Biochem Mol Biol; 1997 Jun; 62(2-3):195-9. PubMed ID: 9393954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cortisol and oestradiol on hepatic 11beta-hydroxysteroid dehydrogenase type 1 and glucocorticoid receptor proteins in late-gestation sheep fetus.
    Gupta S; Alfaidy N; Holloway AC; Whittle WL; Lye SJ; Gibb W; Challis JR
    J Endocrinol; 2003 Feb; 176(2):175-84. PubMed ID: 12553866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In the search for specific inhibitors of human 11beta-hydroxysteroid-dehydrogenases (11beta-HSDs): chenodeoxycholic acid selectively inhibits 11beta-HSD-I.
    Diederich S; Grossmann C; Hanke B; Quinkler M; Herrmann M; Bähr V; Oelkers W
    Eur J Endocrinol; 2000 Feb; 142(2):200-7. PubMed ID: 10664531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of chenodeoxycholic acid on 11beta-hydroxysteroid dehydrogenase in various target tissues.
    Morris DJ; Souness GW; Latif SA; Hardy MP; Brem AS
    Metabolism; 2004 Jun; 53(6):811-6. PubMed ID: 15164334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 11beta-hydroxysteroid dehydrogenase types 1 and 2: an important pharmacokinetic determinant for the activity of synthetic mineralo- and glucocorticoids.
    Diederich S; Eigendorff E; Burkhardt P; Quinkler M; Bumke-Vogt C; Rochel M; Seidelmann D; Esperling P; Oelkers W; Bähr V
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5695-701. PubMed ID: 12466373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guinea pig 11beta-hydroxysteroid dehydrogenase type 1: primary structure and catalytic properties.
    Pu X; Yang K
    Steroids; 2000 Mar; 65(3):148-56. PubMed ID: 10699594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of 11 beta-hydroxysteroid dehydrogenase 1 and 2 in the developing ovine fetal liver and kidney.
    Langlois DA; Matthews SG; Yu M; Yang K
    J Endocrinol; 1995 Dec; 147(3):405-11. PubMed ID: 8543910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone, insulin-like growth factor-I and the cortisol-cortisone shuttle.
    Stewart PM; Toogood AA; Tomlinson JW
    Horm Res; 2001; 56 Suppl 1():1-6. PubMed ID: 11786677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of 11β-hydroxysteroid dehydrogenase 1 and 2 in patients with chronic rhinosinusitis and their possible contribution to local glucocorticoid activation in sinus mucosa.
    Jun YJ; Park SJ; Kim TH; Lee SH; Lee KJ; Hwang SM; Lee SH
    J Allergy Clin Immunol; 2014 Oct; 134(4):926-934.e6. PubMed ID: 24810847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local modulation by 11beta-hydroxysteroid dehydrogenase of glucocorticoid effects on the activity of 15-hydroxyprostaglandin dehydrogenase in human chorion and placental trophoblast cells.
    Patel FA; Sun K; Challis JR
    J Clin Endocrinol Metab; 1999 Feb; 84(2):395-400. PubMed ID: 10022390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and functional consequences of 11beta-hydroxysteroid dehydrogenase activity in human bone.
    Cooper MS; Walker EA; Bland R; Fraser WD; Hewison M; Stewart PM
    Bone; 2000 Sep; 27(3):375-81. PubMed ID: 10962348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 do not explain abnormal cortisol metabolism in polycystic ovary syndrome.
    Walker BR; Rodin A; Taylor NF; Clayton RN
    Clin Endocrinol (Oxf); 2000 Jan; 52(1):77-80. PubMed ID: 10651756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of 11beta-hydroxysteroid dehydrogenase type 2 by steroid hormones and epidermal growth factor in the Ishikawa human endometrial cell line.
    Darnel AD; Archer TK; Yang K
    J Steroid Biochem Mol Biol; 1999; 70(4-6):203-10. PubMed ID: 10622409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rapid screening assay for inhibitors of 11beta-hydroxysteroid dehydrogenases (11beta-HSD): flavanone selectively inhibits 11beta-HSD1 reductase activity.
    Schweizer RA; Atanasov AG; Frey BM; Odermatt A
    Mol Cell Endocrinol; 2003 Dec; 212(1-2):41-9. PubMed ID: 14654249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Green tea and one of its constituents, Epigallocatechine-3-gallate, are potent inhibitors of human 11β-hydroxysteroid dehydrogenase type 1.
    Hintzpeter J; Stapelfeld C; Loerz C; Martin HJ; Maser E
    PLoS One; 2014; 9(1):e84468. PubMed ID: 24404164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 lowers intraocular pressure in patients with ocular hypertension.
    Rauz S; Cheung CM; Wood PJ; Coca-Prados M; Walker EA; Murray PI; Stewart PM
    QJM; 2003 Jul; 96(7):481-90. PubMed ID: 12881590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of 11beta-hydroxysteroid dehydrogenase enzymes by dietary sodium in the rat.
    McKinnell J; Roscoe D; Holmes MC; Lloyd-MacGilp SA; Kenyon CJ
    Endocr Res; 2000 Feb; 26(1):81-95. PubMed ID: 10711725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of 11beta-hydroxysteroid dehydrogenase type 2 by progesterone, estrogen, and the cyclic adenosine 5'-monophosphate pathway in cultured human placental and chorionic trophoblasts.
    Sun K; Yang K; Challis JR
    Biol Reprod; 1998 Jun; 58(6):1379-84. PubMed ID: 9623596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of 11β-hydroxysteroid dehydrogenase type 1 and 2 in mild and moderate/severe persistent allergic nasal mucosa and regulation of their expression by Th2 cytokines: asthma and rhinitis.
    Jun YJ; Park SJ; Hwang JW; Kim TH; Jung KJ; Jung JY; Hwang GH; Lee SH; Lee SH
    Clin Exp Allergy; 2014 Feb; 44(2):197-211. PubMed ID: 24447082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of 11beta-hydroxysteroid dehydrogenase isozymes by proinflammatory cytokines in osteoblasts: an autocrine switch from glucocorticoid inactivation to activation.
    Cooper MS; Bujalska I; Rabbitt E; Walker EA; Bland R; Sheppard MC; Hewison M; Stewart PM
    J Bone Miner Res; 2001 Jun; 16(6):1037-44. PubMed ID: 11393780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.